<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0001513'>Obesity</z:hpo> is a major risk factor for development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, a proximal cause of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and is also associated with an increased relative risk of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We therefore investigated the susceptibility of transgenic mice carrying human mutated transgenes for amyloid precursor protein (APP (SWE)) and presenilin 1 (PSEN1 (A246E)) (APP/PSEN1), or PSEN1 (A246E) alone, which are well-characterised animal models of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, to develop <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and whether this was age- and/or diet-dependent </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We analysed the effects of age and/or diet on body weight of <z:mp ids='MP_0002169'>wild-type</z:mp>, PSEN1 and APP/PSEN1 mice </plain></SENT>
<SENT sid="3" pm="."><plain>We also analysed the effects of diet on <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis and insulin signalling in these mice </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: While there were no body weight differences between 16-17- and 20-21-month-old PSEN1 mice, APP/PSEN1 mice and their <z:mp ids='MP_0002169'>wild-type</z:mp> controls on standard, low-fat, chow diet, the APP/PSEN1 mice still exhibited impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis, as investigated by <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance tests </plain></SENT>
<SENT sid="5" pm="."><plain>This was associated with increased brain protein tyrosine phosphatase 1B protein levels in APP/PSEN1 mice </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, short-term high-fat diet (HFD) feeding of <z:mp ids='MP_0002169'>wild-type</z:mp>, PSEN1 and APP/PSEN1 mice for a period of 8Â weeks led to higher body <z:mp ids='MP_0005456'>weight gain</z:mp> in APP/PSEN1 than in PSEN1 mice and <z:mp ids='MP_0002169'>wild-type</z:mp> controls </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, HFD-feeding caused fasting <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> and worsening of <z:chebi fb="105" ids="17234">glucose</z:chebi> maintenance in PSEN1 mice, the former being further exacerbated in APP/PSEN1 mice </plain></SENT>
<SENT sid="8" pm="."><plain>The mechanism(s) behind this <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> in PSEN1 and APP/PSEN1 mice appeared to involve increased levels of brain <z:chebi fb="1" ids="50211">retinol</z:chebi>-binding protein 4 and basal phosphorylation of S6 ribosomal protein, and decreased insulin-stimulated phosphorylation of Akt/protein kinase B and extracellular signal-regulated kinase 1/2 in the brain </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: Our results indicate that <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> increases susceptibility to body <z:mp ids='MP_0005456'>weight gain</z:mp> induced by HFD, and to the associated <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
</text></document>